These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 626202)
1. Drug therapy monitoring notes--untapped source of data. Riddiough MA Am J Hosp Pharm; 1978 Mar; 35(3):241, 243. PubMed ID: 626202 [No Abstract] [Full Text] [Related]
2. Food and Drug Administration's adverse drug reaction monitoring program. Lee B; Turner WM Am J Hosp Pharm; 1978 Aug; 35(8):929-32. PubMed ID: 677138 [TBL] [Abstract][Full Text] [Related]
3. The planning of a national drug monitoring system. Esch AF World Health Organ Tech Rep Ser; 1972; 498():44-7. PubMed ID: 4625551 [No Abstract] [Full Text] [Related]
4. Adverse drug reactions: a review for healthcare practitioners. Young LR; Wurtzbacher JD; Blankenship CS Am J Manag Care; 1997 Dec; 3(12):1884-906; quiz 1909-10. PubMed ID: 10178476 [No Abstract] [Full Text] [Related]
5. The Food and Drug Administration Information Center on adverse reactions and hazards. Saiger GL Pharmakotherapia; 1965; 2(2):124-8. PubMed ID: 5875220 [No Abstract] [Full Text] [Related]
6. Drug reaction alerts. Lee B; Groth PE Am J Hosp Pharm; 1977 Jul; 34(7):694-5. PubMed ID: 888832 [No Abstract] [Full Text] [Related]
7. Reporting adverse drug therapy results. Pa Med; 1990 Jun; 93(6):29. PubMed ID: 2367135 [No Abstract] [Full Text] [Related]
8. Experimental designs for clinical trials of new animal drugs. Williams RD J Am Vet Med Assoc; 1972 Dec; 161(11):1385-8. PubMed ID: 4638517 [No Abstract] [Full Text] [Related]
9. Food and drug administration statement of problem. Perez MK J Toxicol Environ Health; 1977 Mar; 2(4):727-30. PubMed ID: 558337 [No Abstract] [Full Text] [Related]
10. Current status of international drug regulation. Lasagna L Med Mark Media; 1978 Feb; 13(2):37-8, 40, 42-5. PubMed ID: 10316569 [No Abstract] [Full Text] [Related]
11. How safe are they? Gorman C Time; 2004 Nov; 164(22):151. PubMed ID: 15631007 [No Abstract] [Full Text] [Related]
12. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Poser S Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225 [No Abstract] [Full Text] [Related]
13. Seizures of Canadian drugs rise as Congress, Customs spar. Carreyrou J Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501 [No Abstract] [Full Text] [Related]
14. The FDA as an information source for family physicians. Rheinstein PH Am Fam Physician; 1991 Sep; 44(3):1037-41. PubMed ID: 1877417 [No Abstract] [Full Text] [Related]
15. 'Dear doctor...'--evaluating the impact of risk communication efforts. Seligman PJ Pharmacoepidemiol Drug Saf; 2003 Jun; 12(4):291-3. PubMed ID: 12812008 [No Abstract] [Full Text] [Related]
16. Adverse drug reactions. The scene revisited--an update. Weston JK; Weston K Clin Toxicol; 1977; 10(1):129-48. PubMed ID: 858224 [No Abstract] [Full Text] [Related]
17. The pharmacist in home health care: Part I--Drugs and the elderly. Fedder DO; Abrams M; Lamy PP Caring; 1984 May; 3(5):28-31. PubMed ID: 10266098 [No Abstract] [Full Text] [Related]
18. Anticholinergics increase risk of adverse drug reactions in elderly. Katz MD Provider; 1993 Apr; 19(4):53. PubMed ID: 10125032 [No Abstract] [Full Text] [Related]
19. An update on new drug breakthroughs. Rodman MJ RN; 1987 Apr; 50(4):63-74. PubMed ID: 3645775 [No Abstract] [Full Text] [Related]
20. Beware of new drugs, study suggests. Levenson D Rep Med Guidel Outcomes Res; 2002 May; 13(10):1-2, 5. PubMed ID: 12492085 [No Abstract] [Full Text] [Related] [Next] [New Search]